» Articles » PMID: 33283194

Endogenous Carbon Monoxide Production and Diffusing Capacity of the Lung for Carbon Monoxide in Sepsis-Induced Acute Respiratory Distress Syndrome

Overview
Specialty Critical Care
Date 2020 Dec 7
PMID 33283194
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Low-dose inhaled carbon monoxide is a novel therapeutic under investigation in acute respiratory distress syndrome. The Coburn-Forster-Kane equation is a well-validated model of carbon monoxide uptake that can accurately predict carboxyhemoglobin levels to ensure safe administration of low-dose inhaled carbon monoxide in patients with acute respiratory distress syndrome. Using data from a Phase I trial of low-dose inhaled carbon monoxide, we performed a post hoc analysis to determine if the Coburn-Forster-Kane equation could be used to assess the diffusing capacity of the lung for carbon monoxide and endogenous carbon monoxide production in patients with sepsis-induced acute respiratory distress syndrome. Diffusing capacity of the lung for carbon monoxide was substantially reduced and correlated with Pao/Fio and Sequential Organ Failure Assessment score. Endogenous carbon monoxide production was markedly elevated and was significantly associated with Lung Injury Score in sepsis-induced acute respiratory distress syndrome patients. Our data suggest that the Coburn-Forster-Kane equation can be used to estimate diffusing capacity of the lung for carbon monoxide and endogenous carbon monoxide production in mechanically ventilated patients. We found that increased endogenous carbon monoxide production and reduced diffusing capacity of the lung for carbon monoxide correlate with clinical endpoints associated with outcomes in patients with sepsis-induced acute respiratory distress syndrome.

Citing Articles

"CO in a pill": Towards oral delivery of carbon monoxide for therapeutic applications.

Yang X, Lu W, Wang M, Tan C, Wang B J Control Release. 2021; 338:593-609.

PMID: 34481027 PMC: 8526413. DOI: 10.1016/j.jconrel.2021.08.059.

References
1.
Peterson J, Stewart R . Predicting the carboxyhemoglobin levels resulting from carbon monoxide exposures. J Appl Physiol. 1975; 39(4):633-8. DOI: 10.1152/jappl.1975.39.4.633. View

2.
Fredenburgh L, Perrella M, Barragan-Bradford D, Hess D, Peters E, Welty-Wolf K . A phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDS. JCI Insight. 2018; 3(23). PMC: 6328240. DOI: 10.1172/jci.insight.124039. View

3.
Macnaughton P, Evans T . Measurement of lung volume and DLCO in acute respiratory failure. Am J Respir Crit Care Med. 1994; 150(3):770-5. DOI: 10.1164/ajrccm.150.3.8087351. View

4.
Singh M, Sharan M, Selvakumar S . A mathematical model for the computation of carboxyhaemoglobin in human blood as a function of exposure time. Philos Trans R Soc Lond B Biol Sci. 1991; 334(1269):135-47. DOI: 10.1098/rstb.1991.0103. View

5.
COBURN R, Forster R, Kane P . Considerations of the physiological variables that determine the blood carboxyhemoglobin concentration in man. J Clin Invest. 1965; 44(11):1899-910. PMC: 289689. DOI: 10.1172/JCI105296. View